A. Gray

The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis.

W. El-Sadr, S. A. Abdool Karim, G. Friedland, 2010, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Changes to Antiretroviral Drug Regimens during Integrated TB–HIV Treatment: Results of the Sapit Trial

S. Karim, K. Naidoo, T. Gengiah, 2014, Antiviral therapy.

Improving access to antiretrovirals in rural South Africa - a call to action.

P. Matthews, B. Hwang, F. Venter, 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Initiating antiretrovirals during tuberculosis treatment: a drug safety review

K. Naidoo, T. Gengiah, Q. Karim, 2011, Expert opinion on drug safety.

The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis

N. Holford, S. A. Abdool Karim, K. Naidoo, 2011, European Journal of Clinical Pharmacology.

Enrolling Adolescents in Research on HIV and Other Sensitive Issues: Lessons from South Africa

C. Gray, C. Williamson, S. A. Abdool Karim, 2006, PLoS medicine.

Integration of antiretroviral therapy with tuberculosis treatment.

Anneke Grobler, W. El-Sadr, S. A. Abdool Karim, 2011, The New England journal of medicine.

Timing of initiation of antiretroviral drugs during tuberculosis therapy.

W. El-Sadr, S. A. Abdool Karim, G. Friedland, 2010, The New England journal of medicine.

Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa

S. A. Abdool Karim, K. Naidoo, A. Grobler, 2015, Journal of acquired immune deficiency syndromes.

Initiating antiretrovirals during tuberculosis treatment: a drug safety review

K. Naidoo, T. Gengiah, Q. Karim, 2011, Expert opinion on drug safety.